# Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care

> **NCT07542990** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 266 (estimated)

## Conditions studied

- Delirium in the Intensive Care Unit

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT07542990
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2029-04-15
- **Final completion:** 2029-08-15
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07542990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07542990, "Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07542990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*